IMI JU Governing Board

The Governing Board is composed of ten Board members representing equally the two Founding Members of the IMI Joint Undertaking: five from the European Commission, representing the European Community, and five from the European Federation of Pharmaceutical Industries and Associations (EFPIA), representing the research based pharmaceutical industry in Europe.

Moreover, the European Commission assigned Alain Vanvossel to fulfil the function of Interim Executive Director for the Joint Undertaking.

The IMI JU Governing Board consist of:

From the industry side:

• Brian Ager (EFPIA Director General)
• Andreas Busch (Head of Global Drug Discovery, Bayer HealthCare)
• Jackie Hunter (Senior Vice President , Science Environment Development , GlaxoSmithKline R&D)
• Carlo Incerti (Head of R&D Europe & Co-Chair of European Management Board,
  Genzyme ) 
• Jonathan Knowles (President of Group Research, F. Hoffmann-La Roche)

From the European Commission:

• Zoran Stančič (DG Research, Deputy Director-General)
• Ruxandra Draghia-Akli (DG Research, Director)
• Franco Biscontin (DG Research, Director)
• Georgette Lalis (DG Enterprise, Director)
• Andrzej Jan Rys (DG Sanco, Director)